Article
Clinical Outcomes and Safety of Anakinra in the Treatment of Multisystem Inflammatory Syndrome in Children: a Single Center Prospective Observational Study
2023-04-19
Abstract excerpt
<title>Abstract</title> <p><bold>Background and objective:</bold> Evidence for the treatment of multisystem inflammatory syndrome in children (MIS-C) is lacking. Anakinra, which targets IL-1-mediated inflammation, is reserved for refractory cases of MIS-C; however, its use in the treatment of MIS-C is not clearly established. <bold>Patients and Methods:</bold> To examine a role for anakinra in MIS-C, we performed...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3549818b-6a29-5fe4-95b8-d0adc231617b
- DOI
- 10.21203/rs.3.rs-2773340/v1
